SCHEMBL16615281

SCHEMBL16615281

O=C(Nc1ccc(C(=O)N2CCOCC2)cc1)c1cc2c([nH]1)NCCN2Cc1c(Cl)ccc(F)c1Cl

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.41
NPC1 O15118 5/20 0.41
LMNA P02545 4/20 0.41
MAPT P10636 3/20 0.41
HTT P42858 3/20 0.41
ALDH1A1 P00352 2/20 0.41
HPGD P15428 1/20 0.41
PDE4A P27815 1/20 0.41
PDE7A Q13946 1/20 0.41
KMT2A Q03164 4/20 0.41
EPHX2 P34913 3/20 0.41
RAB9A P51151 4/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MEN1 O00255 2/20 0.39
MAPK1 P28482 1/20 0.39
KDM4E B2RXH2 1/20 0.38
PKM P14618 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17969743 0.87 MAPT (0.45) SMN1; SMN2NPC1LMNAMAPTHTT
SCHEMBL17918849 0.84 MET (0.43) SMN1; SMN2NPC1LMNAMAPTHTT
SCHEMBL17918718 0.79 CFTR (0.42) SMN1; SMN2NPC1LMNAMAPTHTT
SCHEMBL16615212 0.77 MET (0.45) NPC1MAPTALDH1A1HPGDKMT2A
SCHEMBL16615213 0.76 EPHX2 (0.43) SMN1; SMN2NPC1LMNAMAPTHTT
SCHEMBL17918788 0.76 RAB9A (0.46) SMN1; SMN2NPC1LMNAMAPTHTT
SCHEMBL16615317 0.76 MAPT (0.44) SMN1; SMN2NPC1LMNAMAPTHTT
SCHEMBL18106085 0.75 MET (0.54) KMT2AEPHX2MEN1
SCHEMBL16615101 0.74 MET (0.46) SMN1; SMN2NPC1MAPTALDH1A1HPGD
SCHEMBL16615282 0.73 NTRK1 (0.44) SMN1; SMN2NPC1LMNAMAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015047133-A1 NOVEL CHEMICAL COMPOUNDS (VARIANTS) AND THE USE THEREOF TO TREAT ONCOLOGICAL DISEASES ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "ОТЕЧЕСТВЕННЫЕ ФАРМАЦЕВТИЧЕСКИЕ ТЕХНОЛОГИИ" 2015-04-02 WO disclosed